Emil D. Kakkis
2013
In 2013, Emil D. Kakkis earned a total compensation of $685.5K as President and Chief Executive Officer at Ultragenyx Pharmaceutical, a 71% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $140,910 |
|---|---|
| Option Awards | $218,873 |
| Salary | $306,034 |
| Other | $19,721 |
| Total | $685,538 |
Kakkis received $306K in salary, accounting for 45% of the total pay in 2013.
Kakkis also received $140.9K in non-equity incentive plan, $218.9K in option awards and $19.7K in other compensation.
Rankings
In 2013, Emil D. Kakkis' compensation ranked 8,222nd out of 12,286 executives tracked by ExecPay. In other words, Kakkis earned more than 33.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,222 out of 12,286 | 33rd |
Division Manufacturing | 2,978 out of 4,612 | 35th |
Major group Chemicals And Allied Products | 929 out of 1,462 | 37th |
Industry group Drugs | 704 out of 1,156 | 39th |
Industry Pharmaceutical Preparations | 556 out of 890 | 38th |
Source: SEC filing on April 18, 2016.
Kakkis' colleagues
We found two more compensation records of executives who worked with Emil D. Kakkis at Ultragenyx Pharmaceutical in 2013.